South Shore Health and Aspire Health Alliance have announced the establishment of a clinical affiliation to advance behavioral health services for patients on the South Shore and improve access to care. The organizations will collaborate on the planning, development and implementation of integrated...

The new program is designed to provide intensive, structured care for individuals who need more support than traditional outpatient therapy, while still allowing participants to live at home and continue their daily routines.

Two programs within the Grayken Center for Treatment at South Shore Health will transition to a new, spacious location at 797 Main Street, Weymouth. Learn more about the new location of the bridge program and perinatal behavioral health program.

It was an evening of dinner, line dancing, and vying for a chance to win fabulous raffle prizes as the Friends of South Shore Health’s signature event raised more than $20,000 to support Home Care services.

Did you know that the Bridge Program, part of the Grayken Center for Treatment at South Shore Health has treated 1,765 people and performed 14,236 office visits since its inception? And, through the efforts of the nationally-sponsored, Weymouth-based HEAL (Helping End Addiction Long-term) Initiative...

More than 390 business leaders and supporters of South Shore Health recently gathered at Pinehills Golf Club in Plymouth and Plymouth Country Club to help raise money for Behavioral Health and Substance Use Disorder (SUD) services on the South Shore. The South Shore Health annual Golf Classic, held...

More than 400 people attended the spectacular event, held October 21 at Union Point in Weymouth.

The signature event will be held outdoors at Union Point in Weymouth.

The October 21 signature event will raise money for The Grayken Center for Treatment at South Shore Health.

It was a magical autumn evening under the stars as more than 400 turned out to support the Grayken Center for Treatment at South Shore Health at this year's Moonlight & Miracles Gala.